Grace Therapeutics (GRCE) Sale and Maturity of Investments (2011 - 2024)
Grace Therapeutics' Sale and Maturity of Investments - Total was $15,000 in FY2025 (year ended Mar 31, 2025), down 99.8% from $6.57 million in FY2024.
Grace Therapeutics (GRCE) Sale and Maturity of Investments (2011 - 2024) Analysis & Trends
From FY2012 onward, Grace Therapeutics has reported Sale and Maturity of Investments - Total for 13 fiscal years.
- Sale and Maturity of Investments - Total has now declined for three consecutive fiscal years, with a five-year compound annual growth rate of -73.0% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Sale and Maturity of Investments - Total in data going back to FY2012.
- Per Business Quant data, Sale and Maturity of Investments - Total in earlier fiscal years was $6.57 million in FY2024 (-63.9%), $18.19 million in FY2023 (-42.1%), $31.41 million in FY2022 and $21,000 in FY2021 (-99.8%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 6.57 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Sep 30, 2022 | -96,000.00 |
| Jun 30, 2022 | 13.28 Mn |
| Mar 31, 2022 | 88,000.00 |
| Dec 31, 2021 | 13.88 Mn |
| Sep 30, 2021 | 16.06 Mn |
| Jun 30, 2021 | 1.37 Mn |
| Sep 30, 2020 | 21,000.00 |
| Mar 31, 2020 | 10.38 Mn |
| Dec 31, 2019 | -61,000.00 |
| Sep 30, 2019 | 3.39 Mn |
| Jun 30, 2019 | 7.56 Mn |
| Mar 31, 2019 | 9.94 Mn |
| Feb 28, 2017 | 3.05 Mn |
| Nov 30, 2016 | 3.61 Mn |
| Aug 31, 2016 | 7.23 Mn |
| May 31, 2016 | 9.38 Mn |
| Nov 30, 2015 | 3.88 Mn |
| Aug 31, 2015 | 6.08 Mn |
Grace Therapeutics Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();